BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB targets 2x the daily returns of the biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 20.64% 37.60% 32.12% 46.06% 111.88% 31.78% 2.64% 10.06% 18.42% 04/07/2010
BIB Market Price 20.69% 37.84% 32.29% 46.17% 112.02% 31.79% 2.65% 10.08% 18.42% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $91,184,103
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 9/15/2026
  • NAV
    $108.55
  • NAV Change
    $-3.18 down caret
  • Market Price
    $108.43
  • Market Price Change
    $-3.30 down caret
  • Trading Volume (M)
    6,749
  • 30-Day Median Bid Ask Spread
    0.23%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $91,184,103
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 9/15/2026
  • NAV
    $108.55
  • NAV Change
    $-3.18 down caret
  • Market Price
    $108.43
  • Market Price Change
    $-3.30 down caret
  • Trading Volume (M)
    6,749
  • 30-Day Median Bid Ask Spread
    0.23%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 6/30/2026

Holdings

as of 9/15/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.43% VRTX VERTEX PHARMACEUTICALS INC -- $4,041,389.39 7,853 2931034
4.30% AMGN AMGEN INC -- $3,918,780.80 10,432 2023607
4.19% GILD GILEAD SCIENCES INC -- $3,824,574.60 26,142 2369174
2.93% REGN REGENERON PHARMACEUTICALS -- $2,673,001.83 3,453 2730190
2.10% MRNA MODERNA INC -- $1,913,003.62 13,306 BGSXTS3
1.60% RVMD REVOLUTION MEDICINES INC -- $1,459,217.78 7,123 BL71K91
1.24% ILMN ILLUMINA INC -- $1,127,677.17 5,073 2613990
1.17% BIIB BIOGEN INC -- $1,070,041.50 4,950 2455965
1.17% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,066,019.98 4,474 B00FWN1
1.04% ROIV ROIVANT SCIENCES LTD -- $952,345.00 24,110 BMW4NZ9
1.00% ARGX ARGENX SE - ADR -- $909,217.28 928 BDVLM39
0.96% INSM INSMED INC -- $871,338.72 7,266 2614487
0.95% RPRX ROYALTY PHARMA PLC- CL A -- $869,039.61 14,863 BMVP7Y0
0.89% INCY INCYTE CORP -- $815,292.78 6,697 2471950
0.86% GH GUARDANT HEALTH INC -- $780,939.90 4,446 BFXC911
0.78% UTHR UNITED THERAPEUTICS CORP -- $712,498.40 1,424 2430412
0.71% VTRS VIATRIS INC -- $649,882.80 39,032 BMWS3X9
0.65% MEDP MEDPACE HOLDINGS INC -- $592,558.40 955 BDCBC61
0.55% JAZZ JAZZ PHARMACEUTICALS PLC -- $505,983.83 2,101 B4Q5ZN4
0.55% NBIX NEUROCRINE BIOSCIENCES INC -- $505,567.40 3,370 2623911
0.54% ASND ASCENDIS PHARMA A/S -- $494,885.28 2,064 BWXJHM8
0.53% EXEL EXELIXIS INC -- $479,496.30 8,427 2576941
0.50% SMMT SUMMIT THERAPEUTICS INC -- $452,626.20 26,013 BMTVQS7
0.49% BBIO BRIDGEBIO PHARMA INC -- $448,843.57 6,563 BK1KWG8
0.46% HALO HALOZYME THERAPEUTICS INC -- $422,237.50 3,974 2975098
0.46% BMRN BIOMARIN PHARMACEUTICAL INC -- $417,442.65 6,477 2437071
0.44% MDGL MADRIGAL PHARMACEUTICALS INC -- $405,003.24 774 BD59BS7
0.44% TEM TEMPUS AI INC-CL A -- $402,634.80 5,848 BSLSJJ0
0.42% ONC BEONE MEDICINES LTD-ADR -- $383,229.00 1,106 BYYWPW6
0.41% BNTX BIONTECH SE-ADR -- $376,897.62 3,898 BK6H543
0.39% AXSM AXSOME THERAPEUTICS INC -- $351,816.68 1,724 BYZR4X4
0.37% ARWR ARROWHEAD PHARMACEUTICALS IN -- $333,562.40 4,720 BYQBFJ8
0.37% KRYS KRYSTAL BIOTECH INC -- $333,313.20 990 BD6JX35
0.36% SNY SANOFI-ADR -- $330,550.40 7,796 2964557
0.35% CYTK CYTOKINETICS INC -- $314,944.64 4,544 BBBSBJ5
0.34% KYMR KYMERA THERAPEUTICS INC -- $312,180.85 2,759 BMPRZV5
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $309,170.40 2,156 BDCBCD8
0.32% PRAX PRAXIS PRECISION MEDICINES I -- $292,874.40 936 BQ721R4
0.32% TXG 10X GENOMICS INC-CLASS A -- $292,055.14 3,926 BKS3RS7
0.32% TWST TWIST BIOSCIENCE CORP -- $288,214.70 2,087 BGKG6G7
0.31% PCVX VAXCYTE INC -- $286,517.19 4,839 BKPVGH6
0.31% IBRX IMMUNITYBIO INC -- $285,754.70 35,105 BNSP0B8
0.30% CAI CARIS LIFE SCIENCES INC -- $269,980.50 9,473 BT18HP9
0.29% SYRE SPYRE THERAPEUTICS INC -- $265,028.30 2,914 BQBBDY8
0.29% IONS IONIS PHARMACEUTICALS INC -- $261,576.00 5,536 BDJ0LS6
0.28% ALKS ALKERMES PLC -- $256,985.49 5,583 B3P6D26
0.28% IMVT IMMUNOVANT INC -- $252,261.95 6,883 BJRFSB7
0.24% RYTM RHYTHM PHARMACEUTICALS INC -- $222,377.46 2,298 BF2YWG4
0.24% CGON CG ONCOLOGY INC -- $214,530.35 2,957 BRBCSP4
0.23% ABVX ABIVAX SA-ADR -- $207,347.04 1,944 BLC89B2
0.22% SRRK SCHOLAR ROCK HOLDING CORP -- $200,700.00 4,014 BFZQ0L8
0.21% TVTX TRAVERE THERAPEUTICS INC -- $194,843.67 3,117 BLFGJD5
0.21% MIRM MIRUM PHARMACEUTICALS INC -- $192,025.50 2,045 BJDX8Y8
0.21% COGT COGENT BIOSCIENCES INC -- $187,534.72 5,728 BLR6XK8
0.20% LGND LIGAND PHARMACEUTICALS -- $186,407.54 673 2501578
0.20% ORKA ORUKA THERAPEUTICS INC -- $186,244.00 2,020 BKVF0J2
0.20% PTCT PTC THERAPEUTICS INC -- $182,178.75 2,775 B17VCN9
0.20% XENE XENON PHARMACEUTICALS INC -- $182,122.08 3,236 BRJ3GY4
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $177,971.85 10,689 BFNF1D6
0.19% ERAS ERASCA INC -- $169,390.00 10,424 BNLYBF3
0.18% CRSP CRISPR THERAPEUTICS AG -- $167,566.39 3,233 BDHF4K6
0.17% EWTX EDGEWISE THERAPEUTICS INC -- $157,286.15 3,605 BKY5JZ8
0.17% ACAD ACADIA PHARMACEUTICALS INC -- $153,548.88 5,738 2713317
0.16% ADPT ADAPTIVE BIOTECHNOLOGIES -- $143,111.52 5,364 BJ5FZ74
0.15% IOVA IOVANCE BIOTHERAPEUTICS INC -- $140,091.12 14,967 BF0DMK7
0.15% INDV INDIVIOR PHARMACEUTICALS INC -- $139,891.36 4,088 BTZRLN8
0.15% RLAY RELAY THERAPEUTICS INC -- $136,394.30 7,190 BN2R582
0.15% DFTX DEFINIUM THERAPEUTICS INC -- $134,503.46 3,653 BV2DHY6
0.14% AMLX AMYLYX PHARMACEUTICALS INC -- $123,616.35 3,729 BPCK358
0.13% ABCL ABCELLERA BIOLOGICS INC -- $116,781.35 10,235 BL53SR3
0.13% KNSA KINIKSA PHARMACEUTICALS INTE -- $116,707.95 1,553 BRXB0C0
0.13% TNGX TANGO THERAPEUTICS INC -- $115,866.50 4,850 BP2P6L0
0.12% TARS TARSUS PHARMACEUTICALS INC -- $112,885.89 1,443 BMH5RL1
0.12% IDYA IDEAYA BIOSCIENCES INC -- $110,833.38 2,943 BK0VHF6
0.12% GRAL GRAIL INC -- $109,205.71 1,439 BSLSSX7
0.12% ELVN ENLIVEN THERAPEUTICS INC -- $108,961.12 2,042 BMFD115
0.12% DNLI DENALI THERAPEUTICS INC -- $108,401.22 5,319 BD2B4V0
0.12% VCYT VERACYTE INC -- $107,494.92 2,678 BFTWZY0
0.11% GPCR STRUCTURE THERAPEUTICS INC -- $101,815.30 2,614 BQS9486
0.11% DYN DYNE THERAPEUTICS INC -- $99,130.20 5,538 BN15WD1
0.11% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $98,577.43 4,193 BKX9VD3
0.11% MBX MBX BIOSCIENCES INC -- $97,239.36 1,592 BQXJKH2
0.10% QURE UNIQURE NV -- $91,328.90 2,119 BJFSR88
0.10% PHVS PHARVARIS NV -- $89,060.40 2,340 BMZ2X38
0.10% GMAB GENMAB A/S -SP ADR -- $86,843.45 2,543 BBC9WC7
0.09% IRON DISC MEDICINE INC -- $86,278.60 1,282 BMGJZJ8
0.09% NRIX NURIX THERAPEUTICS INC -- $85,961.46 3,462 BMVLGP2
0.09% PGEN PRECIGEN INC -- $83,671.00 11,953 BKM5C84
0.09% -- NEWAMSTERDAM PHARMA CO NV -- $82,862.56 3,916 BP8JSP4
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $81,851.97 1,941 BKSGZN7
0.09% VERA VERA THERAPEUTICS INC -- $81,043.69 2,407 BL55460
0.09% SUPN SUPERNUS PHARMACEUTICALS INC -- $80,372.16 1,947 B72ZBG4
0.09% MLYS MINERALYS THERAPEUTICS INC -- $79,993.97 2,767 BP9N0G0
0.09% BEAM BEAM THERAPEUTICS INC -- $79,923.24 3,442 BK6L288
0.08% OCUL OCULAR THERAPEUTIX INC -- $74,784.41 7,339 BNZB1X8
0.08% SRPT SAREPTA THERAPEUTICS INC -- $73,307.36 3,538 B8DPDT7
0.08% TRVI TREVI THERAPEUTICS INC -- $71,620.48 4,762 BJH9ZN0
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $69,523.20 8,520 2100362
0.08% AUPH AURINIA PHARMACEUTICALS INC -- $69,407.39 4,303 BFWLC09
0.08% KOD KODIAK SCIENCES INC -- $69,213.02 2,098 BFXC933
0.08% RAPP RAPPORT THERAPEUTICS INC -- $68,586.76 1,607 BR3T9B6
0.07% URGN UROGEN PHARMA LTD -- $68,161.42 1,633 BZ7PJQ1
0.07% VCEL VERICEL CORP -- $67,841.76 1,708 BSBMN89
0.07% ZBIO ZENAS BIOPHARMA INC -- $67,659.67 2,119 BQB42H3
0.07% ADMA ADMA BIOLOGICS INC -- $66,899.70 7,770 B9NSBM2
0.07% AGIO AGIOS PHARMACEUTICALS INC -- $65,423.14 1,994 BCBVTX1
0.07% ZYME ZYMEWORKS INC -- $63,744.35 2,447 BPCQZY9
0.07% GHRS GH RESEARCH PLC -- $63,144.60 2,292 BP6C0S2
0.07% NVCR NOVOCURE LTD -- $62,678.15 3,881 BYSS4X4
0.07% FTRE FORTREA HOLDINGS INC -- $62,583.56 3,172 BRXYZ57
0.07% CMPS COMPASS PATHWAYS PLC -- $61,634.03 4,463 BMC3HS7
0.06% VIR VIR BIOTECHNOLOGY INC -- $59,006.88 5,652 BK4PZ38
0.06% XNCR XENCOR INC -- $58,971.25 2,483 BGCYWN8
0.06% STOK STOKE THERAPEUTICS INC -- $58,777.20 2,088 BJQ05Z6
0.06% SEPN SEPTERNA INC -- $58,717.46 1,511 BQNKXX2
0.06% RXRX RECURSION PHARMACEUTICALS-A -- $56,972.16 17,584 BM9FJ13
0.06% PSNL PERSONALIS INC -- $56,462.70 3,507 BJQ0608
0.06% ANIP ANI PHARMACEUTICALS INC -- $54,875.71 761 BCDWBX6
0.06% SNDX SYNDAX PHARMACEUTICALS INC -- $53,745.39 2,971 BN7Q7R7
0.06% ANAB ANAPTYSBIO INC -- $53,367.68 976 BDRW1L7
0.06% NTLA INTELLIA THERAPEUTICS INC -- $53,130.72 4,677 BYZM6C2
0.06% ALVO ALVOTECH SA -- $52,519.24 10,462 BPNTJ34
0.06% INBX INHIBRX BIOSCIENCES INC -- $51,748.90 490 BNSP8K3
0.06% INVA INNOVIVA INC -- $51,495.64 2,471 BDDXF67
0.06% NVAX NOVAVAX INC -- $50,875.76 5,512 BJDQXG4
0.06% TYRA TYRA BIOSCIENCES INC -- $50,707.42 1,994 BMVNDH9
0.06% ETON ETON PHARMACEUTICALS INC -- $50,480.67 919 BGL0JK3
0.05% LEGN LEGEND BIOTECH CORP-ADR -- $49,935.42 2,826 BMX9K07
0.05% BCAX BICARA THERAPEUTICS INC -- $49,919.34 2,202 BQB42F1
0.05% TSHA TAYSHA GENE THERAPIES INC -- $48,732.86 9,631 BNC1BX1
0.05% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $47,376.53 1,491 BLCD809
0.05% MAZE MAZE THERAPEUTICS INC -- $44,995.11 1,857 BSRK699
0.05% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $44,932.96 1,168 BS2CR64
0.05% AVBP ARRIVENT BIOPHARMA INC -- $43,577.26 1,558 BMGTLY5
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $43,367.10 5,790 BLR7H87
0.05% RARE ULTRAGENYX PHARMACEUTICAL IN -- $43,131.00 3,300 BJ62Z18
0.05% ORIC ORIC PHARMACEUTICALS INC -- $42,901.56 3,471 BKVDFF7
0.05% CGEM CULLINAN THERAPEUTICS INC -- $42,291.86 2,059 BM90J52
0.05% HROW HARROW INC -- $42,130.80 1,245 BHNDW86
0.05% OMER OMEROS CORP -- $41,602.91 2,423 B4NB858
0.05% ABSI ABSCI CORP -- $41,526.20 5,230 BN94K69
0.04% VOR VOR BIOPHARMA INC -- $40,577.76 1,818 BRJJYT3
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $39,594.28 3,103 BFYQFJ2
0.04% MNKD MANNKIND CORP -- $36,867.36 10,356 BF081J4
0.04% GLUE MONTE ROSA THERAPEUTICS INC -- $36,748.71 2,829 BP7KZP7
0.04% CRVS CORVUS PHARMACEUTICALS INC -- $36,531.95 2,821 BYP80F1
0.04% CSTL CASTLE BIOSCIENCES INC -- $36,245.50 1,021 BKLCWZ3
0.04% SVRA SAVARA INC -- $36,115.16 6,866 BYXGN81
0.04% REPL REPLIMUNE GROUP INC -- $36,093.10 2,770 BDDVW37
0.04% AMPH AMPHASTAR PHARMACEUTICALS IN -- $34,939.92 1,478 BNFWZS4
0.04% ALMS ALUMIS INC -- $34,750.80 4,137 BPLQG36
0.04% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $34,021.60 4,945 BMCWKZ2
0.04% KURA KURA ONCOLOGY INC -- $33,640.10 2,977 BYZD465
0.04% JANX JANUX THERAPEUTICS INC -- $33,619.80 2,045 BMFX8Y7
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $33,507.32 6,622 BZ0QMB7
0.03% PCRX PACIRA BIOSCIENCES INC -- $31,785.60 1,320 B3X26D8
0.03% GRFS GRIFOLS SA-ADR -- $30,109.76 4,091 B8K7T65
0.03% SANA SANA BIOTECHNOLOGY INC -- $29,476.48 9,328 BMFJJ97
0.03% TBPH THERAVANCE BIOPHARMA INC -- $29,462.16 1,729 BMNDK09
0.03% WVE WAVE LIFE SCIENCES INC -- $28,771.46 6,451 C08GM13
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $28,714.08 2,936 BMZ4LN0
0.03% GERN GERON CORP -- $28,162.38 21,498 2370381
0.03% ARDX ARDELYX INC -- $28,162.20 8,283 BN89V40
0.03% SLDB SOLID BIOSCIENCES INC -- $27,604.26 3,298 BQHN6C7
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $27,503.20 620 BQD3J33
0.03% ZLAB ZAI LAB LTD-ADR -- $27,354.40 1,103 BD9GVY0
0.03% CADL CANDEL THERAPEUTICS INC -- $27,321.84 2,457 BP0TQC5
0.03% ACRS ACLARIS THERAPEUTICS INC -- $25,845.95 4,678 BYV2W40
0.03% MESO MESOBLAST LTD- SPON ADR -- $25,839.22 1,753 BQS7491
0.03% DSGN DESIGN THERAPEUTICS INC -- $25,599.15 2,094 BMFK3H6
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $24,696.15 705 BL95N25
0.03% AURA AURA BIOSCIENCES INC -- $23,970.88 3,464 BP81R42
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $23,893.39 1,753 BKLXFX5
0.03% COLL COLLEGIUM PHARMACEUTICAL INC -- $23,805.60 1,090 BX7RSN3
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,078.65 1,981 BLFBZ32
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $22,403.08 5,518 B3MZ6K5
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $21,836.16 2,676 BJLKVS6
0.02% ANNX ANNEXON INC -- $21,516.88 5,489 BMVV9R5
0.02% SGMT SAGIMET BIOSCIENCES INC-A -- $21,463.92 2,052 BP2NYN2
0.02% OABI OMNIAB INC -- $21,136.65 4,859 BN13S71
0.02% ALT ALTIMMUNE INC -- $21,130.66 6,542 BFY7DC4
0.02% CRMD CORMEDIX INC -- $20,393.28 2,628 BJ0LT31
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $20,240.48 4,208 BYVQJ96
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $19,896.96 11,568 BFZNYB7
0.02% CTMX CYTOMX THERAPEUTICS INC -- $19,631.62 7,298 BYWVTY5
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $19,612.04 1,574 BL5B6Z1
0.02% PRME PRIME MEDICINE INC -- $19,003.28 6,052 BPBJFM7
0.02% TECX TECTONIC THERAPEUTIC INC -- $18,103.85 635 BPBPCG8
0.02% ARVN ARVINAS INC -- $17,882.90 2,165 BDZ30Q0
0.02% NGNE NEUROGENE INC -- $17,855.70 530 BS2F741
0.02% EOLS EVOLUS INC -- $17,457.37 2,207 BDRJH21
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $15,789.75 1,707 B7F2TY6
0.02% KMDA KAMADA LTD -- $15,621.79 1,931 B2Q9833
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $15,132.90 1,095 BPRBTY7
0.02% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $15,048.00 950 BKC9SX3
0.02% PRTA PROTHENA CORP PLC -- $14,619.15 1,755 B91XRN2
0.02% KYTX KYVERNA THERAPEUTICS INC -- $14,184.48 2,038 BSMLR16
0.02% CABA CABALETTA BIO INC -- $14,179.08 5,464 BK5MWR1
0.02% SPRY ARS PHARMACEUTICALS INC -- $14,144.00 3,328 BMCR7V2
0.02% LKFT LAKEFRONT BIOTHERAPEUTIC-ADR -- $14,071.68 504 B292NQ7
0.02% AVIR ATEA PHARMACEUTICALS INC -- $14,021.63 2,681 BLN9Z50
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $14,005.68 10,452 B4N8MH9
0.02% RGNX REGENXBIO INC -- $13,776.63 1,734 BZ0G875
0.01% LRMR LARIMAR THERAPEUTICS INC -- $13,622.44 3,484 BMXNGZ6
0.01% EDIT EDITAS MEDICINE INC -- $13,528.72 5,144 BZ8FPH3
0.01% CCCC C4 THERAPEUTICS INC -- $12,708.15 3,705 BKX9NQ0
0.01% AUTL AUTOLUS THERAPEUTICS PLC -- $12,702.69 6,721 BFMLGR4
0.01% RCKT ROCKET PHARMACEUTICALS INC -- $12,480.60 3,660 BDFKQ07
0.01% TKNO ALPHA TEKNOVA INC -- $12,399.30 1,797 BP7L561
0.01% BIOA BIOAGE LABS INC -- $12,196.38 1,491 BT9K6D8
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $12,134.36 2,009 BPRB2N7
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $11,970.46 974 B9L5200
0.01% LXEO LEXEO THERAPEUTICS INC -- $10,866.03 2,631 BQ6C357
0.01% SION SIONNA THERAPEUTICS INC -- $10,409.44 1,513 BQKXDX4
0.01% EYPT EYEPOINT INC -- $10,291.92 2,812 BMGS7L1
0.01% VNDA VANDA PHARMACEUTICALS INC -- $10,039.88 2,012 B12W3P6
0.01% UPB UPSTREAM BIO INC -- $9,995.52 1,824 BRCFFK6
0.01% IMRX IMMUNEERING CORP - CLASS A -- $9,617.04 2,166 BMVBZF5
0.01% ACIU AC IMMUNE SA -- $9,144.16 3,412 BZC0D70
0.01% TRDA ENTRADA THERAPEUTICS INC -- $8,930.24 1,298 BP81RK8
0.01% LYEL LYELL IMMUNOPHARMA INC -- $8,553.44 784 BTNMG41
0.01% FULC FULCRUM THERAPEUTICS INC -- $8,440.74 2,233 BJDX8Z9
0.01% IVVD INVIVYD INC -- $8,195.42 9,874 BM8NHS1
0.01% FHTX FOGHORN THERAPEUTICS INC -- $8,095.80 1,965 BMF7DT9
0.01% AVXL ANAVEX LIFE SCIENCES CORP -- $7,578.64 3,106 BYTYP72
0.01% KROS KEROS THERAPEUTICS INC -- $7,405.71 663 BM7V485
0.01% SIGA SIGA TECHNOLOGIES INC -- $7,160.94 2,403 2107437
0.01% PYXS PYXIS ONCOLOGY INC -- $7,066.26 2,122 BLBR8D5
0.01% CHRS COHERUS ONCOLOGY INC -- $6,881.42 5,174 BRK0149
0.01% PEPG PEPGEN INC -- $6,710.58 2,322 BMTX3D7
0.01% VYGR VOYAGER THERAPEUTICS INC -- $6,254.16 2,024 BY7RB53
0.01% NBP NOVABRIDGE BIOSCIENCES -- $5,981.58 3,762 BKRRKY7
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $5,725.20 1,560 BKDQKM6
0.01% MENS JYONG BIOTECH LTD -- $5,401.76 2,548 BPTK6Z2
0.01% LFCR LIFECORE BIOMEDICAL INC -- $5,195.70 1,255 2517058
0.01% NMRA NEUMORA THERAPEUTICS INC -- $5,162.37 6,210 BN4JN37
0.01% TNYA TENAYA THERAPEUTICS INC -- $4,874.54 7,270 BNNXX52
0.01% QSI QUANTUM-SI INC -- $4,774.32 6,631 BNR5QT9
-- LENZ LENZ THERAPEUTICS INC -- $4,441.50 1,050 BQV0J03
-- CDXS CODEXIS INC -- $4,274.20 3,053 B5LL2C2
-- CRBU CARIBOU BIOSCIENCES INC -- $4,221.48 3,324 BNYJR68
-- HUMA HUMACYTE INC -- $4,104.46 7,441 BMYTJP4
-- BDTX BLACK DIAMOND THERAPEUTICS I -- $3,784.37 1,921 BKTV702
-- AARD AARDVARK THERAPEUTICS INC -- $3,679.66 733 BTXQTX3
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,096.23 3,769 BNNXX18
-- -- GOSSAMER BIO INC COMMON STOCK USD 0.0001 -- $1,017.24 98 --
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
35.66% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 32,517,776 -- 4,721 --
35.53% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 32,393,794 -- 4,703 --
30.84% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 28,116,408 -- 4,082 --
19.93% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 18,177,168 -- 2,639 --
18.98% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 17,309,293 -- 2,513 --
4.75% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 4,332,489 -- 629 --
-- IQMM PROSHARES GENIUS MNY MKT ETF -- $17,008,500.00 170,000 BTGTPK8
-- -- NET OTHER ASSETS (LIABILITIES) -- $24,858,985.58 24,858,986 --

Index

as of 6/30/2026

  • Total Number of Holdings251
  • Price/Book Ratio5.57
  • Dividend Yield ( % )0.53
  • Avg. Index Market Capitalization$7.18 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.